4.2 Review

Herpes zoster and postherpetic neuralgia: Past, present and future

Journal

PAIN RESEARCH & MANAGEMENT
Volume 14, Issue 4, Pages 275-282

Publisher

HINDAWI LTD
DOI: 10.1155/2009/380384

Keywords

Herpes zoster; Neuropathic pain; Postherpetic neuralgia; Varicella

Funding

  1. Merck Frosst Canada, Ltd
  2. Allon Therapeutics (Canada)
  3. Endo Pharmaceuticals (USA)
  4. Johnson Johnson (USA)
  5. KAI Pharmaceuticals (USA)
  6. WEX Pharmaceuticals (Canada)
  7. Xanodyne Pharmaceuticals (USA)
  8. Trophos SA (France)
  9. Purdue

Ask authors/readers for more resources

OBJECTIVES: The history behind the current understanding of the varicella-zoster virus and its relationship to the pain conditions caused by shingles and postherpetic neuralgia are reviewed. The framework for the current conceptualization is Hope-Simpson's latency hypothesis. Data from recent work in virology, neuroanatomy and epidemiology are reviewed, as is work using varicella-zoster virus-infected animals. The recent data largely confirm Hope-Simpson's hypothesis and extend it significantly.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available